| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.0055 |
0.9 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |